DK1499623T3 - Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on - Google Patents

Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on

Info

Publication number
DK1499623T3
DK1499623T3 DK03719968T DK03719968T DK1499623T3 DK 1499623 T3 DK1499623 T3 DK 1499623T3 DK 03719968 T DK03719968 T DK 03719968T DK 03719968 T DK03719968 T DK 03719968T DK 1499623 T3 DK1499623 T3 DK 1499623T3
Authority
DK
Denmark
Prior art keywords
methyl
carbazol
imidazol
tetrahydro
preparation
Prior art date
Application number
DK03719968T
Other languages
English (en)
Inventor
Sandor Molnar
Csaba Szabo
Sos Erzsebet Meszaros
Szabolcs Salyi
Tivadar Tamas
Original Assignee
Teva Gyogyszerg Ar Zartkoeruee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Gyogyszerg Ar Zartkoeruee filed Critical Teva Gyogyszerg Ar Zartkoeruee
Application granted granted Critical
Publication of DK1499623T3 publication Critical patent/DK1499623T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D521/00—Heterocyclic compounds containing unspecified hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
DK03719968T 2002-04-29 2003-04-29 Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on DK1499623T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37632302P 2002-04-29 2002-04-29
PCT/US2003/013221 WO2003093281A1 (en) 2002-04-29 2003-04-29 Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1h-imidazol-1-yl)methyl]-4h-carbazol-4-one

Publications (1)

Publication Number Publication Date
DK1499623T3 true DK1499623T3 (da) 2007-10-08

Family

ID=29401332

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03719968T DK1499623T3 (da) 2002-04-29 2003-04-29 Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on

Country Status (19)

Country Link
US (2) US7098345B2 (da)
EP (1) EP1499623B1 (da)
JP (1) JP2005529142A (da)
KR (1) KR20040104654A (da)
CN (1) CN1665823A (da)
AT (1) ATE364611T1 (da)
AU (1) AU2003223764A1 (da)
CA (1) CA2483566A1 (da)
DE (1) DE60314400T2 (da)
DK (1) DK1499623T3 (da)
ES (1) ES2288606T3 (da)
HR (1) HRP20041070A2 (da)
IL (1) IL164904A0 (da)
MX (1) MXPA04010846A (da)
NO (1) NO20045192L (da)
PL (1) PL373191A1 (da)
PT (1) PT1499623E (da)
WO (1) WO2003093281A1 (da)
ZA (1) ZA200408934B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002230935A1 (en) * 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
KR20040104677A (ko) * 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법
US7696356B2 (en) * 2004-08-17 2010-04-13 Taro Pharmaceutical Industries Limited Process for preparing 1,2,3,9-tetrahydro-9-methyl-3-methylene-4H-carbazol-4-one and ondansetron therefrom
WO2006046253A1 (en) * 2004-10-26 2006-05-04 Ipca Laboratories Limited A one-pot process for the preparation of antiemetic agent, 1,2,3,9-tetrahydro-9-methyl-3[(2-methyl)-1h-imidazole-1-yl)methyl]-4h-carbazol-4-o

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE460359B (sv) 1984-01-25 1989-10-02 Glaxo Group Ltd 3-imidazolylmetyltetrahydrokarbazoloner, foerfarande foer framstaellning av dessa och en farmaceutisk komposition
US4695578A (en) * 1984-01-25 1987-09-22 Glaxo Group Limited 1,2,3,9-tetrahydro-3-imidazol-1-ylmethyl-4H-carbazol-4-ones, composition containing them, and method of using them to treat neuronal 5HT function disturbances
EP0201165B1 (en) 1985-03-14 1994-07-20 Beecham Group Plc Medicaments for the treatment of emesis
GB8518745D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
GB8518742D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518741D0 (en) 1985-07-24 1985-08-29 Glaxo Group Ltd Process
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds
US4859662A (en) 1986-11-28 1989-08-22 Glaxo Group Limited Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances
GB8630071D0 (en) 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
GB8816187D0 (en) * 1988-07-07 1988-08-10 Glaxo Group Ltd Medicaments
US5344658A (en) 1989-06-28 1994-09-06 Glaxo Group Limited Process and composition using ondansetron
GB8914804D0 (en) 1989-06-28 1989-08-16 Glaxo Group Ltd Process
JPH06508836A (ja) 1991-06-26 1994-10-06 セプラコア，インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
CA2106642C (en) 1992-10-14 2005-08-16 Peter Bod Carbazolone derivatives and process for preparing the same
GB9423588D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
GB9423511D0 (en) 1994-11-22 1995-01-11 Glaxo Wellcome Inc Compositions
CN1045437C (zh) 1994-12-29 1999-10-06 中国科学院上海有机化学研究所 恩丹西酮及其生理盐的合成
AU2002230935A1 (en) 2000-10-30 2002-05-15 Teva Pharmaceutical Industries Ltd. Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparation
EP1207160A1 (en) 2000-11-20 2002-05-22 Hanmi Pharm. Co., Ltd. Process for the preparation of 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)-methyl)-4H-carbazol-4-one
SK9892003A3 (en) 2001-01-11 2004-05-04 Teva Pharma An improved process for preparing pure ondansetron hydrochloride dihydrate
WO2003090730A1 (en) 2002-04-25 2003-11-06 Generics [Uk] Limited Novel crystalline forms of celecoxib and other compounds
KR20040104677A (ko) 2002-04-30 2004-12-10 비오갈 기오기스제르갸르 알티. 신규의 온단세트론 결정 형태, 그 제조 방법, 그 신규의결정 형태를 함유하는 약학 조성물 및 이들을 이용한구역질 치료 방법

Also Published As

Publication number Publication date
EP1499623A1 (en) 2005-01-26
MXPA04010846A (es) 2005-01-25
US7098345B2 (en) 2006-08-29
AU2003223764A1 (en) 2003-11-17
ZA200408934B (en) 2006-07-26
IL164904A0 (en) 2005-12-18
US20060252942A1 (en) 2006-11-09
DE60314400D1 (de) 2007-07-26
ATE364611T1 (de) 2007-07-15
DE60314400T2 (de) 2008-02-07
CN1665823A (zh) 2005-09-07
ES2288606T3 (es) 2008-01-16
JP2005529142A (ja) 2005-09-29
CA2483566A1 (en) 2003-11-13
KR20040104654A (ko) 2004-12-10
WO2003093281A1 (en) 2003-11-13
EP1499623B1 (en) 2007-06-13
HRP20041070A2 (en) 2005-02-28
PT1499623E (pt) 2007-08-10
NO20045192L (no) 2005-01-28
PL373191A1 (en) 2005-08-22
US20050020655A1 (en) 2005-01-27

Similar Documents

Publication Publication Date Title
MX2021000795A (es) Compuestos heterociclicos para inhibir la actividad de shp2.
TW200626580A (en) Synthesis of (5-bromo-4-methyl-pyridin-3-ylmethyl)-ethyl-carbamic acid tert-butyl ester
NO20071629L (no) Fremgangsmate for fremstilling av 2,7-oktadienylderivater
MX2023002890A (es) Procesos e intermedios para la preparacion de (s)-5-amino-3-(4-((5-fluoro-2-metoxibenzamido)metil)fenil)-1-(1,1 ,1-trifluoropropan-2-il)-1h-pirazol-4-carboxamida.
ZA202403308B (en) An efficient new process for synthesis of 2-amino-5-chloro-n-,3-dimethylbenzamide
ZA202204277B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
NO20063132L (no) Naftyridinderivater og deres anvendelse som modulatorer av muskarinreceptorer
MXPA05013652A (es) Modulador del receptor canabinoide.
DK1499623T3 (da) Fremgangsmåde til fremstilling af 1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-on
WO2008021491A3 (en) Method for synthesis of 8-alkoxy-9h-isothiazolo[5,4-b]quinoline-3,4-diones
DK0595111T3 (da) Carbazolonderivater og fremgangsmåde til deres fremstilling
WO2004026267A3 (en) Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them
NO20060417L (no) Fremgangsmate til fremstilling av 1-okten fra krakk-C4
WO2004111047A3 (en) Cycloalkanepyrrolopyridines as dp receptor antagonists
IL185329A0 (en) Conversion of 2-pyrazolines to pyrazoles using bromine
DK1102765T3 (da) Fremgangsmåde til syntese af (1H)-benzo[c]quinolizin-3-on-derivater
MX2022006142A (es) Proceso para la sintesis de (3-cloro-2-piridil)hidrazina.
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK1389188T3 (da) Fremgangsmåde til fremstilling af biperiden II
WO2005047215A3 (en) Processes for preparing bicyclo [3.1.0] hexane derivatives, and intermediates thereto
TW200626555A (en) A process for the preparation of 1, 3, 5-trisubstituted pyrazoles via [3+2] cycloaddition
IL173582A0 (en) A process for the preparation of phenyltetrazole derivatives
WO2019097306A3 (en) Synthesis of 5-amino-1-(2,6-dichloro-4-trifluoromethyl-phenyl)-4-ethylsulfanyl-1h-pyrazole-3-carbonitrile and related compounds
ZA202307488B (en) Methods for the preparation of 5-bromo-2-(3-chloro-pyridin-2-yl)-2h-pyrazole-3-carboxylic acid
MA56071A (fr) Procédés de préparation de 3-bromo-1-(3-chloropyridine-2-yl)-1h-pyrazole-5-carboxylate d'éthyle